- Diplomat Pharmacy (NYSE:DPLO): Q3 GAAP EPS of $0.00 in-line.
- More news on: Diplomat Pharmacy, Earnings news and commentary, Healthcare stocks news, Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Diplomat Pharmacy Inc. Company Name:
DPLO Stock Symbol:
Market:
NEW YORK , Feb. 7, 2020 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Thursday, February 13 : Generac Holdings Inc. (NYSE:GNRC) will replace Alexander & Ba...
Buyouts Can Be Big For Penny Stocks But Not In The Way You May Think Penny stocks hold a lot of potential especially if the company is an acquisition target. You always hear the stories of how someone who found a cheap penny stock to buy that ultimately was bought out for much more than in...
Shares of Diplomat Pharmacy (NYSE: DPLO) were down 32% at 11:44 a.m. EST today after the company announced that it's being acquired by OptumRx, UnitedHealth Group 's (NYSE: UNH) pharmacy-care services division. You read that right: The company is being acquired, and shares went dow...